Be prepared to see some rather wild replacement nicotine commericals as lozenges that dissolve three times faster start being sold in 27 unit dose packets that are more akin to packs of cigarettes. It isn't hard to see what's happening as pharm industry nicotine feels the heat of escalating e-cigarette sales and begins going head to head with tobacco industry nicotine. It won't be long before the gloves come off entirely and pharm replacement nicotine is sold beside tobacco industry replacement nicotine. Yep, it's all about replacement. Still just one rule to stay here on the non-replacement side of the bars ... no nicotine today!
Breathe deep, hug hard, live long,
John (Gold x10)
GSK takes smoking cessation
to a new level with mini lozenge[/color] By Michael Johnsen
PARSIPPANY, N.J. (Apr. 27)
GlaxoSmithKline announced Tuesday the launch of its new Nicorette Mini Lozenge, a smaller smoking cessation lozenge that dissolves three times faster than stop-smoking lozenges currently on the market, to U.S. retail healthcare centers. The lozenges will be lined-priced with existing smoking cessation products and will be sold as three small vials each containing 27 lozenges.
The new mini lozenge is expected to drive incremental growth to the category, suggested Roger Scarlett-Smith, in an interview with Drug Store News, because the smaller lozenge size actually satisfies different usage scenarios. “It’s an opportunity for people to use it in a more situational way,” Scarlett-Smith said. For example, the small vials can be discreetly carried in a pocket for the person “on the go.”
And because there are three vials per package, they can be strategically placed in trouble areas for the person attempting to quit smoking, i.e., in the glove compartment box for a person inclined to smoke while driving.
“Smoking is an addiction, and when trying to quit, smokers may need help to address physical nicotine cravings as well as behavior change,” stated Drew Pinsky, the addiction expert featured on VH1’s Celebrity Rehab who has agreed to help promote the product. “Products, like the new Nicorette Mini Lozenge, can help address the physical symptoms associated with quitting.”
As part of the launch, GSK is launching a “Mini Moments” contest on its new Nicorette Facebook page at www.Facebook/Nicorette.com
. The page is designed to help connect smokers interested in quitting, allowing them to provide each other with support throughout the quitting process. The contest offers them the chance to win an opportunity to meed addiction expert Dr. Drew.
Dr. Drew also will be promoting the Mini Moments campaign to his 1.9 million Twitter followers.
GSK plans to fold advertising of its Nicorette Mini Lozenge into its “Quitting **** … Nicorette helps it **** less” campaign with some updated television spots. The campaign takes a slightly different tact than traditional smoking cessation advertisements — instead of warning smokers of the health consequences associated with smoking, the “Quitting ****” campaign speaks more to the benefits. “What we really wanted to do was advertising that was for smokers but against smoking,” Scarlett-Smith said.
In addition to the launch of the new Mini Lozenge offering, GSK will also be rebranding its line of Commit lozenges under the Nicorette banner, meaning now all of GSK’s smoking cessation lozenge and gum products will be branded Nicorette.